Medical/Pharmaceuticals
Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing
SEOUL, South Korea, Nov. 15, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading biotechnology firm specializing in molecular diagnostics (MDx), has announced the opening of an eighth global subsidiary, strategically located in Bogotá,Colombia. The new entity, known as 'Seegene Colombia S.A....
2021-11-15 19:00
1404
Vazyme goes public on Shanghai Stock Exchange today
NANJING, China, Nov. 15, 2021 /PRNewswire/ -- On November 15, 2021, Nanjing
Vazyme Biotech Co., Ltd. (Vazyme) went public on the STAR MARKET of the
Shanghai Stock Exchange under the stock code 688105.
2021-11-15 16:28
2664
Labcorp Opens New Integrated Laboratory, Strengthens Bioanalytical Services In Asia-Pacific
SINGAPORE, Nov. 15, 2021 /PRNewswire/ -- Labcorp
2021-11-15 16:00
2404
Qiming's Portfolio Company Aohua Endoscopy Lands on STAR Market
SHANGHAI, Nov. 15, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Aohua Endoscopy (SHSE: 688212), a leading medical endoscope manufacturer, today landed on the STAR Market. The issue price isCNY 22.5 per share. The stock opened atCNY 33 per share, representing a market cap of CNY...
2021-11-15 15:06
2232
CBC Group Partners with APG to Launch Healthcare Real Estate Platform and Announce US$500 Million First Close of China Life Science Venture
SHANGHAI, Nov. 14, 2021 /PRNewswire/ --CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm, announced today a partnership with APG Asset Management ("APG"), the largest pension provider inthe Netherlands, in a newAsia-Pacific healthcare platform, CBC Healthcare Infrastructure P...
2021-11-15 10:08
2155
InnoCare Announces the Clearance of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 by U.S. FDA
BEIJING, Nov. 14, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a commercial-stage biotech company, announced today the Investigational New Drug (IND) clearance of itsSHP2 (Src Homology 2 domain containing protein tyrosine phosphatase) allosteric inhibitor ICP-189 by the US Food and Drug A...
2021-11-15 08:30
1501
Wision A.I. Achieves CE-MDR Mark Approval for AI-assisted Diagnostic Software Medical Device Supporting Colonoscopy
SHANGHAI, Nov. 15, 2021 /PRNewswire/ -- Wision A.I. Ltd, a startup in the field of artificial intelligence assisted diagnostics for gastrointestinal endoscopy, today announced it received the European CE Mark approval for EndoScreener, its AI-assisted polyp detection software during colonoscopy. ...
2021-11-15 08:30
1462
Gannex Announces China NMPA Approved Phase II and III Protocols of ASC42, an FXR Agonist, for Treatment of Primary Biliary Cholangitis
SHANGHAI, Nov. 15, 2021 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that the protocols of Phase II and III clinical trials of ASC42 to treat patients with primary biliary cholangitis (PBC) has been approved by China National ...
2021-11-15 08:30
2145
Antengene Presents Compelling Preclinical Data on Two Programs at the Society for Immunotherapy of Cancer (SITC) Annual Meeting on November 12, 2021
-ATG-101, a novel PD-L1/4-1BB bispecific antibody, shows potent in vivo anti-tumor efficacy in checkpoint inhibitor resistant/relapsed models while mitigating liver toxicity risk, computational analysis adds support to dosing strategy -ATG-017, an ERK1/2 inhibitor, in vivo combination supports c...
2021-11-15 08:25
2154
Innovent Announces the Results of the Phase Ib Clinical Trial of IBI302, a First-in-class Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2021 American Academy of Ophthalmology
SAN FRANCISCO and SUZHOU, China, Nov. 15, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2021-11-15 08:00
2276
$5M Boost to Innovation in Australia with New Illumina Genomics Lab
New laboratory opens in Melbourne Biomedical Precinct to accelerate the adoption of genomics in healthcare and agriculture inAustralia. MELBOURNE, Australia, Nov. 15, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), the global leader in genomics, today announced the opening of a new, fully eq...
2021-11-15 06:14
5844
Ascensia Diabetes Care Announce Winner of This is Diabetes Art and Photo Competition
BASEL, Switzerland, Nov. 14, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR® blood glucose monitoring (BGM) system portfolio and distributors of the Eversense® continuous glucose monitoring (CGM) system, has announced the winner of its This is Diabe...
2021-11-14 15:00
2232
China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results
HAIKOU, China, Nov. 12, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced the financial results for the qu...
2021-11-13 05:30
4459
Treadwell Therapeutics Announces A Presentation at the 2021 SITC Annual Meeting Featuring a Clinical Trial Update on CFI-402411, a First-in-Class HPK1 inhibitor
NEW YORK, Nov. 12, 2021 /PRNewswire/ -- Treadwell Therapeutics, a clinical-stage biotechnology company developing novel medicines for highly aggressive cancers, today announced a presentation for the Company's CFI-402411 program, an oral, first-in-class inhibitor ofHematopoietic Progenitor Kinase...
2021-11-13 02:56
4044
Global Accelerated Ventures, ACTUAL, and Bioassets Partner to Work With Enterprises to Make Total Decarbonization Possible
HIGH QUALITY, CERTIFIED CREDITS COMPLEMENT MEANINGFUL EMISSIONS REDUCTIONS FOR ENTERPRISES TO MEET THEIR NET-ZERO MANDATES GLASGOW, Scotland, Nov. 12, 2021 /PRNewswire/ -- Global Accelerated Ventures (GAV) and ACTUAL are partnering with Bioassets, to integrate high quality, provenanced carbon cr...
2021-11-12 23:20
4125
Kintor Pharma Announces Dosing of First Patient in Phase II Clinical Trial of KX-826 for the Treatment of Androgenic Alopecia Female Patients in China
SUZHOU, China, Nov. 12, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the company has dosed the first patient in its phase II clinical ...
2021-11-12 14:17
1582
InnoCare to Attend Upcoming Investor Conferences to Share Latest Company Development
BEIJING, Nov. 12, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that the company executives will attend the upcoming investor conferences organized by Goldman Sachs and Morgan Stanley to share company's latest development. Details are as follows: ...
2021-11-12 14:14
1403
The New Era Biotechnology deepens cooperation between China and Belarus in the Great Stone China Belarus Industrial Park (CBIP)
MINSK, Belarus, Nov. 12, 2021 /PRNewswire/ -- As an enterprise in CBIP, the New
Era Biotechnology Co., Ltd. participated in the fourth edition of the China
International Import Expo (CIIE) which opened inShanghai on November 5, 2021.
2021-11-12 09:11
1904
Hetero and Shenzhen Beimei Pharmaceuticals launch antiviral drug Oselavir® in China
Oseltamivir phosphate is used in the treatment of acute uncomplicated influenza infection in adults, adolescents and children BEIJING, Nov. 12, 2021 /PRNewswire/ -- Hetero, a globally renowned vertically integrated pharmaceutical organization and Shenzhen Beimei Pharmaceuticals jointly announced...
2021-11-12 09:00
2485
Recbio Announces Promising Preliminary Results From First-in-Human Study of a COVID-19 Vaccine Candidate With Novel Adjuvant BFA03
* Well tolerated and good safety profile, no SAE or TEAE leading to early discontinuation, no abnormal vital signs/laboratory testing results with clinical significance * 20μg ReCOV induced high titer of anti-SARS-CoV-2 neutralizing antibodies, with at least comparable level than published da...
2021-11-12 07:55
2751
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2931
